Bills & licensing proposals
Track bill number, chamber, sponsor, latest action, effective date, and the precise activity addressed. Committee referral or passage in one chamber is not final enactment.
State legislation · rules · funding
State Policy Map
A careful framework for tracking state-level bills, administrative rules, research appropriations, and controlled-substance decisions affecting ibogaine.
Reading the record
State posture is not one legal question.
A state may have a bill under consideration, a narrowly defined research appropriation, an agency notice, or a separate controlled-substance rule. These records can point in different directions and may change on different calendars. This map treats each record as a distinct policy signal rather than as a single measure of access.
For the wider context that frames these entries, the ibogaine policy overview follows the federal and state questions that often intersect. Definitions also matter: ibogaine’s reference description helps distinguish the substance from the separate legislative, administrative, and funding actions considered here.
Regional differences
Follow the instrument, not the headline.
Active legislation can range from a request for study to a licensing proposal or a directive to examine public funding. An appropriation can authorize planning, research, or a time-limited pilot without changing state scheduling. Administrative agencies may separately publish notices, rules, or implementation materials that alter how an enacted statute is understood.
State action also sits beside federal controls. The DEA’s drug scheduling overview describes the federal framework, while state codes and enforcement guidance can add their own requirements, definitions, or penalties. A reliable entry identifies which authority issued the document and whether it is introduced, enacted, proposed, final, funded, or expired.
Map categories
Three records to keep separate.
Each state is best read through the status of the underlying instrument. The categories below are designed to make divergence visible without turning an early proposal into a claim about present-day legality.
Rules & agency action
Read health-agency notices, administrative-code updates, emergency orders, and any investigational pathway language in the source record itself.
Funding & research posture
Separate a line-item appropriation, pilot authorization, research directive, and general policy interest. Each has a different legal effect and duration.
“A policy map should show what a document does, who issued it, and when its status was last confirmed.”Ivory Docket review standard
Methodology
Use primary state records first.
The record for each jurisdiction should begin with the state legislature’s bill portal, the enacted session law where applicable, budget and appropriations documents, and the relevant administrative-code or register notice. Law-enforcement guidance belongs in the record only when it is an official, dated statement with clear scope.
For research-related questions, federal materials can clarify the investigational setting without deciding state law. The FDA’s investigational new drug application guidance explains the federal pathway generally; it does not substitute for reviewing a state’s own legislation, funding language, or agency rule.
- 01Record the issuing body and document type before summarizing its practical effect.
- 02Quote the current action date, session, fiscal year, rule stage, or effective date.
- 03Preserve the source link and note whether the record is proposed, enacted, active, repealed, or time-limited.
Policy clarity
Keep the legal record current and specific.
Questions about how sources are selected, dated, and described are addressed in the site’s method and independence statement. For broader policy navigation, ibogaine and depression context may help readers identify adjacent questions without treating general information as legal or medical advice.